Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
62 /100
HIGH RISK
Score updated Oct 13, 2026

RVPH — Reviva Pharmaceuticals Holdings, Inc. Dilution Risk Tracker

Track RVPH dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track RVPH — Get alerts when the score changes →

As of October 13, 2026, Reviva Pharmaceuticals Holdings, Inc. (RVPH) has a DilutionWatch DilutionScore of 62/100, rated HIGH dilution risk. Reviva Pharmaceuticals Holdings, Inc. has a market capitalization of $6.42M, 13.11M shares outstanding, 5 institutional holders tracked. Stored dilution-related fields include 17.58M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
65
📊 Float Risk
25
⚠️ Warrant Exposure
90
🔄 Convertible Debt
15

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 53%
🔄 Reverse Split model est. 65%
• 50-day avg $0.72 below $1 exchange minimum
• 8 months cash with weak price
📜 Warrant Exercise model 60%
• Massive warrant overhang: 134% of shares outstanding
• Warrant risk score very high (90/100)
💰 Capital Raise model 15%
• Under 12 months cash (8mo)
🔔 Track RVPH — Get forecast alerts →

Market Data

Market Cap$6.42M
Shares Outstanding13.11M
Float11.38M
Cash$19.89M
Debt$144.1K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore62/100DilutionWatch score record
Shares Outstanding13.11MVerified float table or market cache
Public Float11.38MVerified float table or market cache
Market Cap$6.42MMarket data cache
Cash Runway7.5 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants17.58MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 4, 8-K 1, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↓ 97.6% shares (2026Q1 vs prior)
5 institutional holders · 391.5K shares
#1 MORGAN STANLEY 341.4K shares
#2 Corient Private Wealth LLC 38.0K shares
#3 Purpose Unlimited Inc. 8.1K shares
+ 2 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest402.0K
Days to Cover12.1
% of Float3.5%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-12
xbrl XBRL CONVERTIBLE 2022-03-15
8-K 8K EVENT 2025-12-23
4 INSIDER TRANSACTION 2025-12-19
4 INSIDER TRANSACTION 2025-12-19
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual RVPH Dilution Snapshot

Reviva Pharmaceuticals Holdings, Inc. (RVPH) has a DilutionScore of 62/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

RVPH's DilutionScore is currently 62/100 (High risk), with 3 score changes tracked over 89 days. The score deteriorated from 74/100 (High risk).

Period Score Risk Level Duration
Sep 13 – Oct 13, 202662/100HIGH31 days
Aug 22 – Sep 12, 202674/100HIGH22 days
Aug 14 – Aug 21, 202668/100HIGH7 days
Jul 16 – Aug 13, 202674/100HIGH29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

RVPH shares outstanding have increased 124.4% from 5.84M (Mar 2026) to 13.11M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 29, 202613.11M11.38M▲ 0.36%
May 27, 202613.11M11.34M▼ 0.86%
May 16, 202613.11M11.44M▲ 2.34%
Apr 07, 202612.81M11.17M▼ 0.33%
Apr 03, 202612.81M11.21M▼ 6.47%
Apr 01, 202612.81M11.99M▲ 122.68%
Mar 28, 202612.73M5.38M▼ 5.15%
Mar 27, 202612.73M5.68M▲ 1.43%
Mar 23, 20265.84M5.60M▲ 0.29%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track RVPH Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment RVPH files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking RVPH — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for RVPH
RVPH FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.